ClearanceBrief
Recall Z-1395-2009 ยท LCP Assay, Glycosylated Hemoglobin

Bio-Rad Laboratories Inc

Bio-Rad Variant II Hemoglobin Testing System with CDM v 4.0, model number 270-2000, Manufactured by Bio-Rad Laboratories, Hercules, CA Measurement of percent hemoglobin Alc is effective in monitoring long-term glucose control in individuals with diabetes mellitus.

DateMay 19, 2009 (initiated Dec 9, 2008)
StatusTerminated
ReasonThe wrong barcode number and tube position number may be assigned to samples leading to discrepant sample results.
Root causePending
ActionRecall initiated on December 10, 2008. Notification conducted by phone call and fax for domestic consignees. Each subsidiary will receive the subsidiary Urgent: Medical Device Correction notice, customer medical device correction response form and number of customers distributed to by e-mail. Each subsidiary must contact customers and provide the customer notice and response form as needed. The notice stated that Bio-Rad Laboratories would release a follow up communication providing a permanent solution upon completion of an investigation. In the interim, it was recommended that customers
Quantity42 units
DistributionWorldwide Distribution -- USA, Argentina, Australia, Brazil, Canada, China, Czech Republic, France, Germany, Hungary, India, Italy, Mexico, New Zealand, Singapore, South Korea, Sweden, Thailand, and the UK.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K063643MODIFICATION TO VARIANT II: HEMOGLOBIN A1C PROGRAM, BETA-THALASSEMIA SHORT PROGRAM AND TOTAL GHB PROGRAM
Bio-Rad Laboratories Inc., Clinical Systems Divisi, Dec 27, 2006